EU consults on risk assessment of carcinogens

Views sought on review of methods for assessing carcinogenic and mutagenic substances;  draft EPTAC assessment out

The European commission has launched a consultation on a draft opinion by three EU scientific committees on risk assessment methods for carcinogenic and mutagenic substances.  The committees were asked to identify harmonised approaches for assessing such substances, but the draft opinion concludes that "each compound requires a case-by-case approach".  The deadline for submissions is 2 December. Meanwhile, the EU has issued a draft impact assessment for the chemical 2,3-epoxypropyltrimethylammonium chloride (EPTAC) used principally in paper production.  See public consultation and draft risk assessment.

Please sign in to access this article. To subscribe, view our subscription options, or take out a free trial.

Please enter your details

Forgotten password?

Having trouble signing in?

Contact Customer Support at
or call 020 8267 8120

Not a subscriber?

Take a free trial now to discover the critical insights and updates our coverage offers subscribers.